Key result
Extrapleural pneumonectomy provides excellent pain relief without 8-month recurrence in a pleural epithelioid hemangioendothelioma case.
Why the study?
Pleural epithelioid hemangioendothelioma is an extremely rare vascular sarcoma with poor treatment response and reduced survival, and no standard treatment is currently available.
Case Report (n=1)
No
Radical surgery may be an effective treatment option for symptomatic primary pleural epithelioid hemangioendothelioma, with no recurrence observed at 8 months in this case.
May support surgical palliation in select rare pleural tumors; leaves open efficacy, safety, and role in larger cohorts.
Epithelioid hemangioendothelioma (EHE) is an extremely rare vascular sarcoma with an unpredictable clinical behavior. Pleural EHEs have been associated with poor response to treatment and reduced survival. To date, no standard treatment for EHE is available. Here we report the case of a 53-year-old man who underwent radical surgery for a symptomatic primary pleural EHE. Clinical presentation was characterized by chronic pain in the left hemithorax with transitory flare, anemia, weight loss and progressive worsening of clinical conditions. After surgery, he resumed active life and normal daily activities and, at 8 months, 18F-FDG PET and computed tomography scan showed no radiological evidence of recurrent disease. Clinical signs of this rare disease, histological features, imaging findings and functional imaging are discussed. We also report a summary of other cases with resected pleural EHE and we briefly review the role of chemotherapeutic, immunomodulatory and antiangiogenic drugs for advanced disease.
No takes yet. Share an insight, caveat, or question.
Lavacchi et al. (2021) conducted a case report in Primary pleural epithelioid hemangioendothelioma (n=1). Extrapleural pneumonectomy was evaluated on Recurrent disease. Extrapleural pneumonectomy in a 53-year-old man with primary pleural epithelioid hemangioendothelioma provided excellent pain relief with no radiological evidence of recurrence at 8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: